Moneycontrol PRO

Alembic Pharma Q2 PAT may dip 49.2% YoY to Rs 169.4 cr: ICICI Direct

Net Sales are expected to decrease by 6.5 percent Y-o-Y (up 2.8 percent Q-o-Q) to Rs 1,363 crore, according to ICICI Direct.

October 19, 2021 / 06:40 PM IST
India business helped by COVID-19 and lower base of last year rose 57 percent to Rs 481 crore.

India business helped by COVID-19 and lower base of last year rose 57 percent to Rs 481 crore.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

ICICI Direct has come out with its second quarter (July-September’ 21) earnings estimates for the Healthcare sector. The brokerage house expects Alembic Pharma to report net profit at Rs 169.4 crore down 49.2% year-on-year (up 2.9% quarter-on-quarter).

Net Sales are expected to decrease by 6.5 percent Y-o-Y (up 2.8 percent Q-o-Q) to Rs 1,363 crore, according to ICICI Direct.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 45 percent Y-o-Y (up 3.4 percent Q-o-Q) to Rs 244 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark